Uniphar plc (AIM:UPR)
London
· Delayed Price · Currency is GBP · Price in GBX 235.00
+5.00 (2.17%)
Apr 17, 2025, 3:07 PM GMT+1
Uniphar Revenue
In the year 2024, Uniphar had annual revenue of 2.77B EUR with 8.51% growth. Uniphar had revenue of 1.40B in the half year ending December 31, 2024, with 30.03% growth.
Revenue
2.77B EUR
Revenue Growth
+8.51%
P/S Ratio
0.27
Revenue / Employee
791.55K EUR
Employees
3,500
Market Cap
612.33M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.77B | 217.37M | 8.51% |
| Dec 31, 2023 | 2.55B | 482.39M | 23.30% |
| Dec 31, 2022 | 2.07B | 127.52M | 6.56% |
| Dec 31, 2021 | 1.94B | 119.30M | 6.54% |
| Dec 31, 2020 | 1.82B | 158.57M | 9.52% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
Uniphar News
- 7 weeks ago - Shares in Uniphar up more than 6pc after results - Independent Ireland
- 7 weeks ago - The week ahead in business: Bank of Ireland, Uniphar and Glanbia to announce results - Independent Ireland
- 2 months ago - Uniphar reports 8pc increase in profits last year - Independent Ireland
- 8 months ago - Uniphar reports increase in profits and revenues in first half of 2024 - Independent Ireland